交易 Aquestive Therapeutics, Inc. - AQST CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.0296 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Aquestive Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 4.4852 | 0.5300 | 13.40% | 3.9552 | 4.5052 | 3.9052 |
Apr 17, 2024 | 3.9052 | 0.0300 | 0.77% | 3.8752 | 4.0352 | 3.8152 |
Apr 16, 2024 | 3.8352 | 0.0500 | 1.32% | 3.7852 | 3.8752 | 3.7052 |
Apr 15, 2024 | 3.9252 | -0.1000 | -2.48% | 4.0252 | 4.0452 | 3.7952 |
Apr 12, 2024 | 3.8952 | -0.1600 | -3.95% | 4.0552 | 4.0852 | 3.7552 |
Apr 11, 2024 | 4.0852 | -0.1300 | -3.08% | 4.2152 | 4.3252 | 4.0652 |
Apr 10, 2024 | 4.0452 | 0.1100 | 2.80% | 3.9352 | 4.1352 | 3.9352 |
Apr 9, 2024 | 4.0752 | 0.0600 | 1.49% | 4.0152 | 4.1552 | 3.9052 |
Apr 8, 2024 | 4.0652 | 0.0800 | 2.01% | 3.9852 | 4.1352 | 3.9352 |
Apr 5, 2024 | 4.0752 | -0.0600 | -1.45% | 4.1352 | 4.2852 | 3.9652 |
Apr 4, 2024 | 4.1452 | -0.0500 | -1.19% | 4.1952 | 4.3152 | 3.8952 |
Apr 3, 2024 | 4.3652 | 0.2800 | 6.85% | 4.0852 | 4.4852 | 4.0452 |
Apr 2, 2024 | 4.1452 | 0.1400 | 3.50% | 4.0052 | 4.2352 | 4.0052 |
Apr 1, 2024 | 4.1152 | -0.1700 | -3.97% | 4.2852 | 4.3452 | 4.0452 |
Mar 28, 2024 | 4.2352 | 0.0300 | 0.71% | 4.2052 | 4.4552 | 4.1652 |
Mar 27, 2024 | 4.0652 | -0.0500 | -1.22% | 4.1152 | 4.1952 | 3.9752 |
Mar 26, 2024 | 4.0452 | -0.0800 | -1.94% | 4.1252 | 4.3152 | 4.0152 |
Mar 25, 2024 | 4.1352 | -0.2400 | -5.49% | 4.3752 | 4.4852 | 4.0052 |
Mar 22, 2024 | 4.3652 | -0.0300 | -0.68% | 4.3952 | 4.5352 | 4.3152 |
Mar 21, 2024 | 4.3452 | -0.1200 | -2.69% | 4.4652 | 4.5452 | 4.1952 |
Aquestive Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Tuesday, April 30, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q1 2024 Aquestive Therapeutics Inc Earnings Release Q1 2024 Aquestive Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
Thursday, June 20, 2024 | ||
时间(协调世界时) (UTC) 13:30 | 国家 US
| 事件 Aquestive Therapeutics Inc Annual Shareholders Meeting Aquestive Therapeutics Inc Annual Shareholders MeetingForecast(预报) -上一页 - |
Monday, August 5, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q2 2024 Aquestive Therapeutics Inc Earnings Release Q2 2024 Aquestive Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 47.68 | 50.832 | 45.849 | 52.609 | 67.43 |
收入 | 47.68 | 50.832 | 45.849 | 52.609 | 67.43 |
收入成本,共計 | 19.386 | 14.989 | 12.964 | 20.361 | 20.988 |
毛利 | 28.294 | 35.843 | 32.885 | 32.248 | 46.442 |
總營業費用 | 89.746 | 99.333 | 88.742 | 110.173 | 116.364 |
銷售/一般/行政費用,總計 | 52.879 | 53.475 | 55.892 | 64.342 | 72.264 |
研究與開發 | 17.481 | 17.047 | 19.886 | 20.574 | 23.112 |
異常費用(收入) | 0 | 13.822 | 0 | 4.896 | |
營業收入 | -42.066 | -48.501 | -42.893 | -57.564 | -48.934 |
利息收入(費用),非經營淨值 | -12.344 | -22.038 | -12.89 | -8.682 | -12.437 |
其他,淨值 | -0.005 | ||||
稅前淨收入 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
稅後淨收入 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
未計算非常項目前的淨收益 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
淨收入 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
Total Adjustments to Net Income | 0 | ||||
普通股股東可獲收益 (不含非經常性項目) | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
普通股股東可獲收益 (含非經常性項目) | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
攤薄淨收入 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
攤薄後加權平均股 | 48.7344 | 38.0777 | 33.6511 | 25.3561 | 20.7255 |
扣除特別項目的每股攤薄盈利 | -1.11646 | -1.8525 | -1.65769 | -2.61263 | -2.96137 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -1.11646 | -1.48951 | -1.65769 | -2.41954 | -2.96137 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 13.241 | 11.134 | 10.682 | 11.463 | 13.265 |
收入 | 13.241 | 11.134 | 10.682 | 11.463 | 13.265 |
收入成本,共計 | 6.617 | 4.737 | 5.305 | 4.625 | 5.242 |
毛利 | 6.624 | 6.397 | 5.377 | 6.838 | 8.023 |
總營業費用 | 17.45 | 16.092 | 21.395 | 20.316 | 26.027 |
銷售/一般/行政費用,總計 | 7.36 | 7.455 | 11.812 | 12.459 | 15.587 |
研究與開發 | 3.473 | 3.547 | 4.278 | 3.232 | 5.198 |
營業收入 | -4.209 | -4.958 | -10.713 | -8.853 | -12.762 |
利息收入(費用),非經營淨值 | -1.299 | 13.026 | -1.639 | -3.683 | -3.54 |
稅前淨收入 | -5.508 | 8.068 | -12.352 | -12.536 | -16.302 |
稅後淨收入 | -5.792 | 8.068 | -12.352 | -12.536 | -16.302 |
未計算非常項目前的淨收益 | -5.792 | 8.068 | -12.352 | -12.536 | -16.302 |
淨收入 | -5.792 | 8.068 | -12.352 | -12.536 | -16.302 |
普通股股東可獲收益 (不含非經常性項目) | -5.792 | 8.068 | -12.352 | -12.536 | -16.302 |
普通股股東可獲收益 (含非經常性項目) | -5.792 | 8.068 | -12.352 | -12.536 | -16.302 |
攤薄淨收入 | -5.792 | 8.068 | -12.352 | -12.536 | -16.302 |
攤薄後加權平均股 | 57.3509 | 73.7929 | 54.4529 | 53.4249 | 45.4625 |
扣除特別項目的每股攤薄盈利 | -0.10099 | 0.10933 | -0.22684 | -0.23465 | -0.35858 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.10099 | 0.11412 | -0.22684 | -0.23465 | -0.35858 |
異常費用(收入) | 0 | 0.353 | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 39.888 | 47.259 | 44.625 | 68.314 | 74.201 |
現金和短期投資 | 27.273 | 28.024 | 31.807 | 49.326 | 60.599 |
現金等價物 | 27.273 | 28.024 | 31.807 | 49.326 | 60.599 |
應收賬款總額,淨額 | 4.704 | 12.12 | 6.955 | 13.13 | 6.481 |
應收賬款 - 貿易,淨額 | 4.704 | 12.12 | 6.955 | 13.13 | 6.448 |
總庫存 | 5.78 | 4.038 | 2.461 | 2.859 | 5.441 |
預付的費用 | 2.131 | 3.077 | 3.402 | 2.999 | 1.68 |
其他流動資産,總計 | |||||
總資産 | 57.07 | 61.993 | 62.884 | 78.479 | 86.851 |
物業/廠房/設備,總計 - 淨額 | 9.296 | 7.78 | 10.321 | 9.726 | 12.207 |
物業/廠房/設備,總計 - 總額 | 51.259 | 47.64 | 51.199 | 47.77 | 47.398 |
累計折舊,總計 | -41.963 | -39.86 | -40.878 | -38.044 | -35.191 |
無形資産,淨額 | 1.435 | 0.051 | 0.102 | 0.439 | 0.204 |
其他長期資産,總計 | 1.451 | 0.903 | 0.836 | 0.239 | |
流動負債總額 | 39.528 | 21.964 | 21.104 | 18.555 | 32.952 |
應付賬款 | 9.946 | 8.314 | 7.089 | 12.274 | 20.436 |
預提費用 | 8.222 | 9.635 | 9.297 | 5.232 | 6.988 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 2.66 | 1.99 | 2.143 | 1.049 | 0.928 |
負債總額 | 175.624 | 144.127 | 111.381 | 84.601 | 76.771 |
長期債務總額 | 33.448 | 51.551 | 34.329 | 60.338 | 42.603 |
長期債務 | 33.448 | 51.551 | 34.329 | 60.338 | 42.603 |
其他負債,總計 | 102.648 | 70.612 | 55.948 | 5.708 | 1.216 |
總權益 | -118.554 | -82.134 | -48.497 | -6.122 | 10.08 |
Redeemable Preferred Stock | 0 | ||||
普通股 | 0.055 | 0.041 | 0.035 | 0.034 | 0.025 |
額外實收資本 | 192.598 | 174.621 | 137.725 | 124.318 | 71.431 |
留存收益(累計赤字) | -311.207 | -256.796 | -186.257 | -130.474 | -61.376 |
總負債和股東權益 | 57.07 | 61.993 | 62.884 | 78.479 | 86.851 |
已發行普通股總數 | 54.8277 | 41.2287 | 34.5692 | 33.5629 | 24.9573 |
長期債務的當前部分/資本租賃 | 18.7 | 2.025 | 2.575 | 0 | 4.6 |
應收票據 - 長期 | 5 | 6 | 7 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 42.457 | 39.788 | 43.706 | 39.888 | 38.087 |
現金和短期投資 | 24.917 | 22.436 | 26.882 | 27.273 | 18.649 |
現金等價物 | 24.917 | 22.436 | 26.882 | 27.273 | 18.649 |
應收賬款總額,淨額 | 8.55 | 10.101 | 7.551 | 4.704 | 10.737 |
應收賬款 - 貿易,淨額 | 8.55 | 10.101 | 7.551 | 4.704 | 10.737 |
總庫存 | 7.079 | 5.95 | 6.981 | 5.78 | 6.725 |
預付的費用 | 1.911 | 1.301 | 2.292 | 2.131 | 1.976 |
總資産 | 59.448 | 56.994 | 61.285 | 57.07 | 51.845 |
物業/廠房/設備,總計 - 淨額 | 10.22 | 10.38 | 9.698 | 9.296 | 6.378 |
物業/廠房/設備,總計 - 總額 | 52.932 | 52.879 | 51.945 | 51.259 | 48.007 |
累計折舊,總計 | -42.712 | -42.499 | -42.247 | -41.963 | -41.629 |
無形資産,淨額 | 1.317 | 1.357 | 1.396 | 1.435 | 1.487 |
應收票據 - 長期 | 4 | 4 | 5 | 5 | 5 |
其他長期資産,總計 | 1.454 | 1.469 | 1.485 | 1.451 | 0.893 |
流動負債總額 | 24.057 | 38.653 | 40.383 | 39.528 | 36.56 |
應付賬款 | 9.994 | 10.689 | 12.44 | 9.946 | 11.072 |
預提費用 | 5.835 | 4.61 | 4.836 | 8.222 | 8.579 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 4.606 | 18.362 | 17.195 | 18.7 | 14.225 |
其他流動負債,總計 | 3.622 | 4.992 | 5.912 | 2.66 | 2.684 |
負債總額 | 162.375 | 163.645 | 170.52 | 175.624 | 159.664 |
長期債務總額 | 34.555 | 20.801 | 25.196 | 33.448 | 38.675 |
長期債務 | 34.555 | 20.801 | 25.196 | 33.448 | 38.675 |
其他負債,總計 | 103.763 | 104.191 | 104.941 | 102.648 | 84.429 |
總權益 | -102.927 | -106.651 | -109.235 | -118.554 | -107.819 |
普通股 | 0.067 | 0.062 | 0.056 | 0.055 | 0.054 |
額外實收資本 | 207.972 | 202.218 | 193.848 | 192.598 | 190.982 |
留存收益(累計赤字) | -310.966 | -308.931 | -303.139 | -311.207 | -298.855 |
總負債和股東權益 | 59.448 | 56.994 | 61.285 | 57.07 | 51.845 |
已發行普通股總數 | 66.7408 | 61.616 | 55.9224 | 54.8277 | 53.8521 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -54.41 | -70.539 | -55.783 | -66.246 | -61.376 |
经营活动产生的现金 | -9.789 | -32.979 | -45.459 | -60.21 | -12.991 |
经营活动产生的现金 | 2.387 | 2.964 | 3.443 | 2.905 | 3.186 |
Amortization | 0.05 | ||||
非现金物品 | 10.227 | 36.326 | 11.294 | 14.255 | 37.151 |
已付现金利息 | 6.436 | 6.438 | 8.491 | 7.34 | 6.049 |
营运资金的变化 | 32.007 | -1.73 | -4.413 | -11.124 | 7.998 |
投资活动产生的现金 | -2.524 | -0.913 | -0.517 | -0.663 | -1.824 |
资本支出 | -2.524 | -0.913 | -0.517 | -0.663 | -1.824 |
其他投资现金流量项目,总计 | |||||
融资活动产生的现金 | 11.562 | 30.109 | 28.457 | 49.6 | 58.035 |
融资现金流项目 | -0.003 | -0.014 | -3.008 | -6.773 | -10.795 |
股票的发行(报废),净额 | 13.59 | 30.123 | 6.215 | 39.317 | 68.83 |
债务的发行(退还),净额 | -2.025 | 0 | 25.25 | 17.056 | 0 |
现金净变化 | -0.751 | -3.783 | -17.519 | -11.273 | 43.22 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 8.068 | -54.41 | -42.058 | -29.522 | -13.22 |
Cash From Operating Activities | 8.816 | -9.789 | -18.235 | -21.044 | -14.482 |
Cash From Operating Activities | 0.325 | 2.387 | 1.99 | 1.394 | 0.727 |
Non-Cash Items | 0.14 | 10.227 | 9.567 | 6.802 | 2.689 |
Cash Interest Paid | 1.466 | 6.436 | 1.609 | 1.609 | 1.609 |
Changes in Working Capital | 0.283 | 32.007 | 12.266 | 0.282 | -4.678 |
Cash From Investing Activities | -0.002 | -2.524 | -2.498 | -0.781 | -0.104 |
Capital Expenditures | -0.002 | -2.524 | -2.498 | -0.781 | -0.104 |
Cash From Financing Activities | -9.205 | 11.562 | 11.358 | 11.496 | 1.298 |
Financing Cash Flow Items | -0.008 | -0.003 | -0.003 | 0 | |
Issuance (Retirement) of Stock, Net | 0.916 | 13.59 | 12.711 | 12.171 | 1.298 |
Net Change in Cash | -0.391 | -0.751 | -9.375 | -10.329 | -13.288 |
Issuance (Retirement) of Debt, Net | -10.113 | -2.025 | -1.35 | -0.675 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Aquestive Therapeutics, Inc. Company profile
关于 Aquestive Therapeutics Inc.
Aquestive Therapeutics, Inc.是一家制药公司。 该公司专注于开发和商业化利用药膜的差异化产品。 其后期产品管线侧重于治疗中枢神经系统(CNS)疾病,早期阶段的管线包括治疗过敏性休克。 它的商业化许可产品是Suboxone,一种丁丙诺啡和纳洛酮的舌下膜制剂,用于治疗阿片类药物依赖。 其专注于癫痫的中枢神经系统产品组合包括:Sympazan,一种氯巴占的口服可溶性薄膜制剂,用于治疗与一种罕见的难治性癫痫(Lennox-Gastaut综合症)有关的发作。 其产品组合还包括Suboxone,一种丁丙诺啡和纳洛酮的舌下膜制剂,分别是阿片类药物的激动剂和拮抗剂,用于治疗阿片类药物依赖。
Industry: | Pharmaceuticals (NEC) |
30 Technology Dr
WARREN
NEW JERSEY 07059-5166
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球610,000万多名交易者的一份子,选择利用Capital.com进行交易吧。